SCHEMBL20045451

SCHEMBL20045451

CNc1n[nH]c2c(C)c(C)ccc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YTHDC1 Q96MU7 2/20 0.33
YTHDF2 Q9Y5A9 2/20 0.33
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
USP2 O75604 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
PTPN1 P18031 1/20 0.31
PDE2A O00408 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
P2RY12 Q9H244 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8404435 0.76 ADORA2A (0.47) CYP1A2HSD17B10ADORA2AADORA2BPDE2A
SCHEMBL20434719 0.75 CHEK1 (0.46) CYP3A4CLK4ADORA2AADORA2BKDM4E
SCHEMBL25677897 0.73 ADORA2A (0.33) ADORA2AADORA2BKDM4ENPC1ALDH1A1
SCHEMBL25667856 0.73 ADORA2A (0.33) ADORA2AADORA2BKDM4ENPC1ALDH1A1
SCHEMBL25667714 0.73 ADORA2A (0.37) ADORA2AADORA2BKDM4ENPC1ALDH1A1
SCHEMBL25669560 0.73 ADORA2A (0.33) ADORA2AADORA2BKDM4ENPC1ALDH1A1
SCHEMBL25667807 0.73 ADORA2A (0.33) USP2ALOX15ADORA2AADORA2BKDM4E
SCHEMBL25669809 0.70 POLB (0.35) ADORA2AADORA2BPDE2APDE3BPDE3A
SCHEMBL25667671 0.70 ADRA2A (0.38) YTHDC1YTHDF2PDE2APDE3BPDE3A
SCHEMBL22239632 0.68 ADORA1 (0.44) ADORA2AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018068017-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF RAS AND METHODS OF USE THEREOF ARAXES PHARMA LLC (US) 2018-04-12 WO disclosed